Celgene to acquire Gloucester Pharmaceuticals

Celgene agreed to pay $640 million to take over Gloucester Pharmaceuticals, a biotech firm in Massachusetts. The acquisition comes a month after Gloucester received approval for Istodax, a treatment for T-cell lymphoma.

View Full Article in:

Modern Healthcare (free registration) · Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC